Peptides AcademyStopping Mounjaro
Mounjaro is tirzepatide approved for type 2 diabetes, the same molecule and dose ladder as Zepbound, and often prescribed off-label for weight loss. SURMOUNT-4, the tirzepatide withdrawal trial, was run in people without diabetes, so treat its numbers as a guide for Mounjaro users.
- Molecule
- tirzepatide
- Doses
- 2.5–15 mg weekly
- Half-life
- about 5 days
- Clears in
- about 4 weeks
Approved for type 2 diabetes (often prescribed off-label for weight loss). Full tirzepatide profile
What to expect week by week
With a half-life of about 5 days, Mounjaro does not switch off the day you stop. The share of drug left, estimated from the half-life alone:
Week 1
38%
Week 2
14%
Week 3
5%
Week 4
2%
Week 5
1%
Week 6
0%
- First 1–2 weeks: little change for most people. Nausea and other gastrointestinal side effects usually start to ease.
- Weeks 2–4: appetite, portion size and "food noise" typically come back as levels fall, and larger meals feel comfortable again.
- From week 5: the drug is largely cleared. What happens to the weight from here depends on the habits in place.
Weight regain after stopping tirzepatide
SURMOUNT-4
Everyone took tirzepatide at the highest tolerated dose (10 or 15 mg) for 36 weeks and lost about 20.9% of body weight. Participants were then randomized to continue or switch to placebo for 52 weeks.
Those who continued lost a further 5.5%. Those switched to placebo regained 14% of body weight, though most still weighed less than when they started.
Trial summaryParticipants stopped with no plan for the months afterwards. The off-ramp guide covers the four things that decide how much comes back.
Blood sugar comes first
If you take Mounjaro for type 2 diabetes, stopping removes one of your glucose-lowering medicines. Agree with your prescriber what replaces it before the last dose; see the section on blood sugar below.
What happens to blood sugar when you stop Mounjaro
Mounjaro lowers blood sugar by boosting insulin release when glucose is high and damping glucagon. As it clears over about 4 weeks, that effect goes with it, and HbA1c usually rises unless another treatment takes over.
Before stopping, agree with your prescriber which medicine replaces it, whether doses of insulin or a sulfonylurea need to change, and how often to check glucose in the weeks afterwards. Report readings above your target rather than waiting for the next routine appointment.
Mounjaro taper schedule
The Mounjaro dose ladder (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) in reverse, about 4 weeks per dose. There is no official taper protocol, and tapering has not been shown to reduce regain in a randomized trial. Take this to your prescriber as a starting point, not a prescription.
| Current dose | Gradual step-down | Shorter step-down |
|---|---|---|
| 15 mg | 12.5 mg → 10 mg → 7.5 mg → 5 mg → 2.5 mg → stop20 weeks | 10 mg → 5 mg → 2.5 mg → stop12 weeks |
| 12.5 mg | 10 mg → 7.5 mg → 5 mg → 2.5 mg → stop16 weeks | 7.5 mg → 2.5 mg → stop8 weeks |
| 10 mg | 7.5 mg → 5 mg → 2.5 mg → stop12 weeks | 5 mg → 2.5 mg → stop8 weeks |
| 7.5 mg | 5 mg → 2.5 mg → stop8 weeks | 2.5 mg → stop4 weeks |
| 5 mg | 2.5 mg → stop4 weeks | 2.5 mg → stop4 weeks |
Stopping Mounjaro: common questions
How long does Mounjaro stay in your system?
Mounjaro (tirzepatide) has a half-life of about 5 days, so it takes around 4 weeks after the last injection for it to clear. Levels fall by about half every 5 days, which is why many people notice appetite returning a couple of weeks after stopping, before the drug is fully gone.
Do you need to taper off Mounjaro?
No official taper exists, and stopping outright is not dangerous for most people. A step-down, running the Mounjaro dose ladder in reverse at about 4 weeks per dose, slows the return of appetite and can show whether a lower dose holds your weight. Tapering has not been proven to reduce regain in a randomized trial. Decide with your prescriber; the Taper Planner lists a gradual and a shorter step-down from every Mounjaro dose.
Will I gain weight after stopping Mounjaro?
Most people in the tirzepatide withdrawal trials regained a large share of the weight within a year. In SURMOUNT-4, people switched from tirzepatide to placebo regained 14% of body weight over a year, while those who continued lost a further 5.5%; most still weighed less than when they started. Results varied widely, and participants stopped with no structured plan. Protein, strength training and an early response to a rising trend are the parts you control.
What happens if you stop Mounjaro cold turkey?
There is no recognized withdrawal syndrome. Gastrointestinal side effects such as nausea usually ease within a few weeks, and appetite and "food noise" typically return as levels fall over about 4 weeks. In type 2 diabetes, blood sugar can also rise, so stopping should be planned with your prescriber.
What happens to blood sugar when you stop Mounjaro?
Mounjaro lowers blood sugar, so HbA1c usually rises after stopping unless another treatment takes over. Your prescriber may start or increase another glucose-lowering medicine, and doses of insulin or a sulfonylurea that were reduced when you started may need to change again. Check glucose more often in the weeks after stopping and report readings above your target.
Can I restart Mounjaro after stopping?
Usually, if your prescriber and coverage allow it. After a gap of more than a couple of weeks, prescribers normally restart at a lower dose and step back up to limit nausea and other side effects. Agree the restart rule, meaning which weight trend triggers it and at what dose, before you stop.
Can I switch to Zepbound instead of stopping Mounjaro?
Mounjaro and Zepbound contain the same molecule (tirzepatide); Zepbound is approved for weight management rather than type 2 diabetes, so coverage rules usually decide which one you can get. If cost or coverage is why you are stopping, ask your prescriber whether a switch, a lower dose or another option makes sense. The dose ladders differ, so a switch needs a new dosing plan.
Plan the rest of the off-ramp
Stopping a GLP-1: the guide
What the withdrawal trials show and the four things that decide whether the weight stays off.
OpenTaper Planner
Step-down schedules for every dose, protein targets and the 16-week calendar.
OpenOff-Ramp Checklist
The printable one-pager to take to your prescriber before the last dose.
OpenEducational content only, not medical advice. Whether and how to reduce or stop a prescription GLP-1 is a decision for you and your prescriber, especially if you take it for type 2 diabetes or take other glucose-lowering medicines. The step-down tables mirror the label dose ladders in reverse; they are a starting point for that conversation, not a prescription.